Frontlight ResearchEarly access
Head and neck cancer trials in Japan
28 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
- Where
- Aichi, Aomori, Chiba, Ehime, Fukuoka, Gunma, Hokkaido, Hyōgo, Kagoshima, Kanagawa, Kyoto, Miyagi, Niigata, Numakunai, Okinawa, Osaka, Saitama, Shizuoka, Tokyo, Tottori
- Age
- 18 years and over
- People
- 864 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06256588 · EU 2023-508613-17-00 - Phase 1/2Taking peopleA Study of MT-4561 in Patients With Various Advanced Solid Tumors
- Where
- Chuo Ku, City
- Age
- 18 years and over
- People
- 27 worldwide
- Run by
- Tanabe Pharma America, Inc.
See details and how to joinNCT06943521 - Phase 3Taking peopleA Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases
- Where
- Aichi, Hiroshima, Kyoto, Tokyo, Yonago
- Age
- 18 years and over
- People
- 412 worldwide
- Run by
- Rakuten Medical, Inc.
See details and how to joinNCT06699212 · EU 2025-523017-28-00